FDA Letter API

North Texas Vapor Shop

Letter data

Company
North Texas Vapor Shop
Recipient
Jeremy Speight | North Texas Vapor Shop | 347 East Hickory Street | Denton | , | TX | 76201 | United States | BigTexVaporShop@gmail.com
Issue date
2019-09-27
Posted date
Not available
FDA office
Center for Tobacco Products
Subject
Not available
Product
Tobacco
CMS ID
589383
Reference number
RW1901147
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: 21-CFR-1100.221-CFR-1143.121-CFR-1143.3(b)21-CFR-1143.3(b)(1)21-CFR-1143.3(b)(2)21-CFR-PART-1143

21 U.S.C.: 21-USC-321(rr)21-USC-387

Related FDA links

No related FDA letter link is present in the source index.

Full source text

WARNING LETTER North Texas Vapor Shop MARCS-CMS 589383 — September 27, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Product: Tobacco Recipient: Recipient Name Jeremy Speight North Texas Vapor Shop 347 East Hickory Street Denton , TX 76201 United States BigTexVaporShop@gmail.com Issuing Office: Center for Tobacco Products 10903 New Hampshire Avenue Silver Spring , MD 20993 United States SEP 27, 2019 WARNING LETTER Dear Jeremy Speight: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://bigtexvaporshop.com and determined that the e-liquid products listed there are manufactured and offered for sale or distribution to customers in the United States. Under section 201(rr) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. § 321(rr)), as amended by the Family Smoking Prevention and Tobacco Control Act, these products are tobacco products because they are made or derived from tobacco and intended for human consumption. Certain tobacco products, including e-liquids, are subject to FDA jurisdiction under section 901(b) of the FD&C Act (21 U.S.C. § 387a(b)). FDA has determined that several e-liquid products advertised and offered for sale or distribution on your website are misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)) because your website advertising the e-liquid products fails to include the required nicotine warning statement. E-Liquid Products with Labeling and/or Advertising that Fails to Include the Required Nicotine Warning Statement are Misbranded Our review of the website https://bigtexvaporshop.com revealed that the labeling and/or advertising for several e-liquid products that you manufacture, package, import, distribute, or retail does not include the required nicotine warning statement, for example: Bavarian Cream, Gummy Bear, Candy Apple Rancher, Cinna-Bomb, and Banana Nut Bread. Under 21 C.F.R. § 1143.3(b), advertising for cigarette tobacco, roll-your-own tobacco, and covered tobacco products (other than cigars), such as e-liquid products, must bear the following warning statement: WARNING: This product contains nicotine. Nicotine is an addictive chemical. For cigarette tobacco, roll-your-own tobacco, and covered tobacco products other than cigars, it is unlawful for a tobacco product manufacturer, packager, importer, distributor, or retailer of the tobacco product to advertise or cause to be advertised within the United States any tobacco product unless each advertisement bears the required warning statement (21 C.F.R. § 1143.3(b)(1)). Further, the required warning statement must meet the requirements of 21 C.F.R. § 1143.3(b)(2). Under 21 C.F.R. § 1143.1, a “covered tobacco product” is defined as any tobacco product deemed to be subject to the FD&C Act under 21 C.F.R. § 1100.2, excluding components or parts not made or derived from tobacco. Before 21 C.F.R. § 1100.2 became effective, only cigarettes, smokeless tobacco, roll-your-own tobacco, and cigarette tobacco were subject to chapter IX of the FD&C Act. 21 C.F.R. § 1100.2 deems all other tobacco products, except accessories of such tobacco products, subject to chapter IX and its implementing regulations. The products cited in this violation are “covered tobacco products.” Under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)), tobacco products are misbranded if sold or distributed in violation of regulations prescribed under section 906(d) of the FD&C Act, including those within 21 C.F.R. Part 1143. Because your website regarding e-liquid products does not include the required nicotine warning statement for these products, in violation of 21 C.F.R. § 1143.3(b), your e-liquid products are misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)). Conclusion and Requested Actions The violation discussed in this letter does not necessarily constitute an exhaustive list. You should immediately correct the violation that is referenced above, as well as violations that are the same as or similar to the one stated above, and take any necessary actions to bring your tobacco products into compliance with the FD&C Act. It is your responsibility to ensure that your tobacco products and all related labeling and/or advertising on this website, on any other websites (including e-commerce, social networking, or search engine websites), in any other media in which you advertise, and in any retail establishments comply with each applicable provision of the FD&C Act and FDA’s implementing regulations. Failure to ensure full compliance with the FD&C Act may result in FDA initiating further action without notice, including, but not limited to, civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, and/or injunction. Please note that any adulterated and misbranded tobacco products offered for import into the United States are subject to detention and refusal of admission. Please submit a written response to this letter within 15 working days from the date of receipt describing your corrective actions, including the dates on which you discontinued the violative labeling, advertising, sale, and/or distribution of these tobacco products and your plan for maintaining compliance with the FD&C Act. If you do not believe that your products are in violation of the FD&C Act, include your reasoning and any supporting information for our consideration. You can find the FD&C Act through links on FDA’s homepage at http://www.fda.gov . Please note your reference number, RW1901147 , in your response and direct your response to the following address: DPAL-WL Response, Office of Compliance and Enforcement FDA Center for Tobacco Products c/o Document Control Center Building 71, Room G335 10903 New Hampshire Avenue Silver Spring, MD 20993-0002 If you have any questions about the content of this letter, please contact Ele Ibarra-Pratt at (301) 796-9235 or via email at CTPCompliance@fda.hhs.gov . Sincerely, /S/ Ann Simoneau, J.D. Director Office of Compliance and Enforcement Center for Tobacco Products VIA UPS, USPS, and Electronic Mail cc: Big Tex Vapor Bar Attn: Thao M. Huynh 324 E. McKinney Street Denton, Texas 76201 North Texas Vapor Shop, LLC d/b/a Big Tex Vapor Shop Attn: Jeremy K. Speight P.O. Box 1733 Denton, Texas 76202-1733 GoDaddy.com, LLC abuse@godaddy.com Shopify, Inc. abuse@shopify.com Content current as of: 10/15/2019 Regulated Product(s) Tobacco